Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature-Reference-Cited by-同舟云学术

Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literature

Published:2022-11-27 Issue:1 Volume:21 Page:65-76
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Grau Santiago¹,Miró Jose Maria²³,Olalla Julian⁴,Alcalá Juan C⁵,Castro Antonio⁵,Rubio-Rodríguez Dario⁶,Rubio-Terrés Carlos⁶

Affiliation:

1. Pharmacy Department, Hospital Del Mar, Barcelona, Spain

2. Department of Infectious Diseases, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain

3. CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain

4. Internal Medicine Department, Hospital Costa Del Sol, Marbella, Spain

5. Gilead Sciences, Madrid, Spain

6. Health Value, Madrid, Spain

Funder

Gilead Sciences Spain

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2023.2149490

Reference103 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. Unidad de Vigilancia de VIH, Conductas de R. Mortalidad por VIH y sida en España, año 2017. Evolución 1981-2017. Centro Nacional de Epidemiología, Instituto de Salud Carlos III/ Plan Nacional sobre el Sida, Dirección General de Salud Pública, Calidad e Innovación. Madrid

3. 2019. Available from: https://www.mscbs.gob.es/ca/ciudadanos/enfLesiones/enfTransmisibles/sida/vigilancia/doc/MortalidadXVIH2017.pdf (cited 2020 May 29). • Mortality due to HIV and AIDS in Spain. Evolution 1981-2017.

4. Dirección General de Salud Pública. Calidad e Innovación. Informe de evaluación. Plan estratégico de prevención y control del VIH e ITS de 2013-2016. Plan Nacional del SIDA. 2018. Available from: https://www.mscbs.gob.es/ciudadanos/enfLesiones/enfTransmisibles/sida/planesEstrat/informeEvaluacion_VDweb_12Dicbre18.pdf (cited 2019 Jun 30). • Strategic plan for the prevention and control of HIV in Spain (2013-2016).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review;AIDS Research and Therapy;2023-10-27